|
Tatva Chintan Pharma Chem Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
1780.14 Cr.
|
P/BV
|
2.41
|
Book Value (Rs.)
|
315.32
|
|
52 Week High/Low (Rs.)
|
1222/621
|
FV/ML
|
10/1
|
P/E(X)
|
311.63
|
|
Bookclosure
|
20/09/2024
|
EPS (Rs.)
|
2.44
|
Div Yield (%)
|
0.13
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 382.71 | 390.50 | 420.89 | 431.29 | 296.86 |
| Other Operating Revenues | 0.00 | 3.01 | 2.72 | 2.35 | 3.50 |
| Total Operating Revenues | 382.71 | 393.50 | 423.61 | 433.65 | 300.36 |
| | | | | | |
| Other Income | 2.32 | 7.51 | 5.74 | 8.89 | 5.93 |
| Total Revenue | 385.03 | 401.01 | 429.36 | 442.54 | 306.29 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 173.76 | 178.76 | 215.82 | 254.49 | 150.91 |
| Purchase Of Stock-In Trade | 2.98 | 3.60 | 4.58 | 3.68 | 2.54 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | 22.20 | -8.18 | 5.71 | -63.53 | -4.06 |
| Employee Benefit Expenses | 52.92 | 54.76 | 38.60 | 30.81 | 24.13 |
| Finance Costs | 1.29 | 6.53 | 8.40 | 4.83 | 4.21 |
| Depreciation And Amortisation Expenses | 27.66 | 25.61 | 9.56 | 8.18 | 6.73 |
| Other Expenses | 96.64 | 96.37 | 98.33 | 99.96 | 61.13 |
| Total Expenses | 377.45 | 357.45 | 380.99 | 338.42 | 245.60 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 7.58 | 43.57 | 48.37 | 104.12 | 60.70 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | -3.59 | 0.00 | 0.00 |
| Profit/Loss Before Tax | 7.58 | 43.57 | 44.78 | 104.12 | 60.70 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 1.87 | 7.64 | 2.89 | 18.98 | 10.81 |
| Deferred Tax | 0.00 | 5.57 | -3.59 | -10.73 | -2.38 |
| Total Tax Expenses | 1.87 | 13.21 | -0.71 | 8.25 | 8.43 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 5.71 | 30.35 | 45.49 | 95.87 | 52.26 |
| | | | | | |
| Profit/Loss From Continuing Operations | 5.71 | 30.35 | 45.49 | 95.87 | 52.26 |
| | | | | | |
| Profit/Loss For The Period | 5.71 | 30.35 | 45.49 | 95.87 | 52.26 |
| Consolidated Profit/Loss After MI And Associates | 5.71 | 30.35 | 45.49 | 95.87 | 52.26 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 2.44 | 13.26 | 20.52 | 44.59 | 26.02 |
| Diluted EPS (Rs.) | 2.44 | 13.26 | 20.52 | 44.59 | 26.02 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 0.00 | 4.68 | 4.43 | 0.00 | 4.02 |
